ImpediMed Ltd (IPD) Stock Price & News

IPD:ASX

ImpediMed Ltd

A$0.0040

0.00%

(0.00) 1D

Nov 3, 4:10:15 PM GMT+11 · AUD

All symbols

	Symbol	Price	Change	% Change

Awaiting results...

Call Time: Thu, Oct 29, 6:00 PM

Fiscal period

Q1 2027

- / -

Revenue / Est. (AUD)

- / 4.90M

Fiscal Q1 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in AUD

Loading Previous Earnings...

All values in AUD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.76M	3.76M	3.55M	3.55M
Cost of goods sold	470.00K	470.00K	451.50K	451.50K
Cost of revenue	470.00K	470.00K	451.50K	451.50K
Research and development expenses	36.50K	36.50K	65.00K	65.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.69M	6.69M	6.45M	6.45M
Operating expense	8.72M	8.72M	8.29M	8.29M
Total operating expenses	9.19M	9.19M	8.74M	8.74M
Operating income	-5.43M	-5.43M	-5.19M	-5.19M
Other non operating income	-	-	-324.00K	-324.00K
EBT including unusual items	-6.13M	-6.13M	-6.31M	-6.31M
EBT excluding unusual items	-6.13M	-6.13M	-6.31M	-6.31M
Income tax expense	7.00K	7.00K	6.00K	6.00K
Effective tax rate	-0.11%	-0.11%	-0.10%	-0.10%
Other operating expenses	935.50K	935.50K	719.00K	719.00K
Net income	-6.14M	-6.14M	-6.31M	-6.31M
Net profit margin	-163.41%	-163.41%	-177.89%	-177.89%
Earnings per share	-	-	-	-
Interest and investment income	234.00K	234.00K	133.00K	133.00K
Interest expense	-936.00K	-936.00K	-927.00K	-927.00K
Net interest expenses	-702.00K	-702.00K	-794.00K	-794.00K
Depreciation and amortization charges	1.05M	1.05M	1.06M	1.06M
EBITDA	-4.38M	-4.38M	-4.82M	-5.16M
Gain or loss from assets sale	-	-	-	-

Finance